$CLS

MIONIS ROBERT sold $8.5M of CLS (indirect holdings)

MIONIS ROBERT (Chief Executive Officer) sold 23,496 indirectly-held shares of CELESTICA INC (CLS) at an average of $362.39 ($360.37–$365.34, $8.51M total) across 6 trades on 2026-08-13 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · MIONIS ROBERT
Published Aug 14, 2026, 8:12 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 14, 2026, 8:51 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$CLS
Neutral
medium confidence
Mentioned
$CLS
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CLSNeutralLow
01

Why it matters

Traders may use the disclosed sale size and execution window to gauge short-term sentiment and potential supply overhang, but it is not a fundamental catalyst like earnings, guidance, or a deal.

02

Market read

A CEO sold about $8.5M of CLS shares across six trades at roughly $360 to $365, disclosed via Form 4 filed on 2026-08-14.

03

What to watch

The filing is indirect holdings and does not reveal whether other insiders or the company simultaneously bought shares, so net insider signal may be incomplete.

Relevance 5/10Novelty 5/10Timing: filed 2026-08-14 after-hours; sale executed 2026-08-13

Background

The article is an SEC Form 4 insider transaction disclosure for Celestica (CLS) by CEO Mionis Robert, indicating an open-market sale under a 10b5-1 plan.

Company-level read

Ticker impact

$CLSNeutralMedium confidence
Context

Celestica CEO Mionis Robert sold $8.51M of CLS via an open-market sale under a pre-arranged 10b5-1 plan on 2026-08-13.

Expected impact

Likely limited, sentiment-driven pressure around the filing date, with no clear directional edge beyond positioning.

Evidence & confidence

Form 4 shows a large CEO sale ($8.51M) across multiple trades, but it is explicitly under a 10b5-1 plan, reducing the signal of new negative information.

Market effects

Minimal sector read-through; this is company-specific insider activity rather than guidance, contracts, or regulatory action.

None indicated.

None indicated.

Counterpoint

Because the sale is under a pre-arranged 10b5-1 plan, the market may overreact; price impact could fade quickly.

Key entities

  • CELESTICA INC

    Company whose shares were sold by its CEO under a Form 4 disclosure.

  • MIONIS ROBERT

    Chief Executive Officer and director who executed the sale.

  • 10b5-1 plan

    Pre-arranged plan that typically reduces the informational content of the sale timing.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CLSMedAI 8/10

Celestica Stock Falls 2.63%: Why TSX:CLS Is in Focus After AI Infrastructure Boom, $20.5 Billion Revenue Outlook and New 2027 Growth Catalysts

Celestica Inc. (TSX:CLS) shares fell 2.63% on Aug. 14, 2026 despite strong Q2 results and raised outlook. Q2 revenue rose about 62% to US$4.70B and adjusted EPS to US$2.54. 2026 revenue guidance was lifted to about US$20.5B, adjusted EPS to US$11.30, and FCF to US$600M, with 2027 growth expected to accelerate on AI infrastructure demand.

$CLSMed

Half Yearly Results Announcement 2026

CLS Holdings plc (CLS) reported half-year results for six months to 30 June 2026. EPRA earnings fell to £10.9m from £16.1m, and statutory loss after tax was £69.6m. Dividend per share was nil. The company said it executed £56.8m of sales, exchanged £18.9m more, refinanced or repaid £113.6m of debt, and invested £12.5m. Vacancy was stable at 14.5%.

$CLSMed

Celestica Completes Equity Offering

Celestica said it completed an equity offering of 11,129,031 common shares, including full exercise of underwriters’ option for 1,451,612 shares. The company expects net proceeds to fund working capital, capital expenditures, and other general corporate purposes. The filing was made via a Canadian base shelf prospectus and a U.S. Form S-3.